News Focus
News Focus
icon url

Tuff-Stuff

12/07/10 9:00 AM

#351031 RE: Tuff-Stuff #351030

Credit Suisse upgrades Novartis (NVS) to Outperform from Neutral, saying the firm "now has the leading revenue growth for 2011 and 2012 relative to EU major pharma peers." Shares +1.9%.